Patients With a Combination of ADHD and DBD Share Genetic Factors Linked to Risky, Aggressive Behavior – Pharmacy Times

Individuals with both attention-deficit/hyperactivity disorder (ADHD) and a disruptive behavior disorder (DBD) share about 80% of genetic variants associated with aggressive and antisocial behaviors, according to new research published in Nature Communications. The study analyzed nearly 4000 patients with these pathologies and 30,000 control individuals, examining the neurobiological basis for aggressive behavior.

Certain people feature 2 or more psychiatric disorders, and this coexistence continues, in many cases, in a chronological axis, in which suffering from a psychiatric disorder such as ADHD involves opening the door to other comorbid pathologies that aggravate the life quality of those who suffer from the disorder, said Marta Ribass, PhD, head of the Laboratory of Genetic Psychiatry of Vall d'Hebrn Research Institute (VHIR), in a press release.

ADHD affects around 5% of children and 2.5% of adults and features hyperactivity, impulsiveness, and attention deficit. It is often associated with additional psychiatric conditions, including DBDs, which can be associated with antisocial and aggressive behaviors.

ADHD and DBD are caused by genetic and environmental factors, said Bru Cormand, professor at the Department of Genetics, Microbiology and Statistics and head of the Research Group on Neurogenetics at the University of Barcelona, in the release. Regarding ADHD, it is estimated that genetics account for 75%, while in DBDs, it would oscillate between 40 and 70%. These clinical pictures are more frequent in boys than girls, and when they come together, people are more likely to fall into risky behaviors, addictive substance use, and premature death.

The investigators identified a genomic segment in chromosome 11 that increases the risk of having ADHD in combination with DBD. This region contains the STIM1 gene, responsible for the regulation of calcium cell levels, neuronal plasticity and learning memory.

Our study shows that genetics are more determining in people with ADHD and DBD than those who only suffer from ADHD, Cormand said in the release. If we compare the genome of patients with ADHD and DBD to that of those patients with only ADHD, we see that people affected by both disorders have a higher genetic correlation with risk genetic variants. These extra correlations of [patients with] ADHD and DBD would probably correspond to alterations other authors had related to aggressive-related behaviors.

According to the investigators, this study will help broaden the understanding of the genetic landscape of ADHD comorbidities, enabling the prediction of potential secondary complications for these patients.

If we consider ADHD to be an open door to a negative trajectory, using genetic information to identify those individuals who are more vulnerable will have a strong impact on prevention, early detection, and treatment, and will shed light on new research studies to find efficient therapies that can be specific for the disorder or shared between several disorders, Ribass said in the release.

REFERENCE

ADHD, DBD and aggressiveness: Risky genetic factors [news release]. EurekAlert; February 17, 2021. Accessed July 13, 2021. https://www.eurekalert.org/pub_releases/2021-02/uob-ada021721.php

Continue reading here:
Patients With a Combination of ADHD and DBD Share Genetic Factors Linked to Risky, Aggressive Behavior - Pharmacy Times

Getting to the heart of genetic cardiovascular diseases | Penn Today – Penn Today

When she isnt pursuing her favorite heart-pumping activities of running, swimming, or cycling, Sharlene M. Day, a presidential associate professor of cardiovascular medicine and director of Translational Research for the Penn Cardiovascular Institute, is focused on the heart in another way; trying to unlock and treat the mysteries of genetic heart disease.

As part of her research at the Day Lab, Day integrates translational and clinical science to understand the full spectrum of genetic heart disease evolution and progression, from gene mutations in heart muscle cells to ways of predicting negative outcomes in patients. Clinically, she sees patients with hypertrophic cardiomyopathy, a condition where the heart muscle becomes thick making it harder for blood to leave the heart, and other genetic heart conditions at the Penn Center for Inherited Cardiac Disease, such as inherited arrhythmias, high blood cholesterol, Marfan syndrome and familial amyloidosis. Her research program primarily focuses on these same conditions.

A physician scientist, Day completed her residency, followed by a cardiology fellowship, and a postdoctoral research fellowship at the University of Michigan before joining the faculty there, and spent 24 years there before coming to Penn. Day was recruited to Penn Medicine to lead initiatives in translational research within the Cardiovascular Institute and to grow the clinical and academic mission in the Penn Center for Inherited Cardiovascular Disease.

Very early on in my training, I became fascinated with the interplay between genetics and cardiac physiology that manifest in very unique observable cardiac traits and complicated disease trajectories including both heart failure and arrhythmias, also known as irregular heartbeats, says Day.

This story is by Sophie Kluthe. Read more at Penn Medicine News.

Read more:
Getting to the heart of genetic cardiovascular diseases | Penn Today - Penn Today

Lecturer/Senior Lecturer in Genetics job with UNIVERSITY OF GREENWICH | 260037 – Times Higher Education (THE)

School of Science

Location: Medway campusSalary: 33,797 to 49,553 per annumContractType: PermanentClosingDate: Monday 09 August 2021InterviewDate: To be confirmedReference: 2755-E

The School of Science (www.gre.ac.uk/es/science) at the University of Greenwich is a large interdisciplinary School, covering biological sciences, biomedical sciences, food and nutrition, chemistry, pharmaceutical sciences, and forensic science. We have ambitious research and teaching plans as part of our new University Strategy This is our time to ensure that our students are fully prepared for future careers. Collegiality and interdisciplinary research and teaching are key features of the School. Our School is based at the historic Medway campus and boasts amazing learning spaces with state-of-the-art laboratories and lecture theatres.

As part of our ongoing development and expansion of biological, biomedical sciences and forensic science provision within the University, we are seeking to appoint a permanent lecturer/senior lecturer (teaching & research) in genetics (broadest sense). The post holder will have a strong track record at the national and international levels and will establish their own independent research programme. For appointment as Senior Lecturer, you will also have a proven track record of attracting external research and other grants.

Applicants will also be expected to contribute high quality teaching within the School and will be responsible for lectures, tutorials and laboratory classes on the biology, biomedical sciences and forensic sciences degree programmes, as well as academic duties including student assessment, marking and pastoral support. Further, with molecular techniques routinely used for diagnosis and investigation within biosciences and forensics, we seek to appoint a geneticist with knowledge and experience in these methods.

This is an exciting opportunity for a suitably motivated individual to help shape the future of bioscience research and teaching provision within the School.

The post will be based in the School of Science on the Medway campus.

For informal enquiries, please contact the Head of School, Professor Adrian Dobbs onA.Dobbs@gre.ac.uk

Should you have any queries please contact the HR Recruitment Team onHR-Recruitment@gre.ac.uk

We are looking for people who can help us deliver our mission of transforming lives through inspired teaching and research, through ourvalues.

The university welcomes people from diverse and underrepresented communities who can help the university to achieve its mission.

We do this through taking positive action such as encouraging applications from Black, Asian and Minority Ethnic, disabled and LGBT+ people. As part of our commitment to Equality, Diversity and Inclusion, Time to Change Employer Pledge/Mentally Healthy Universities, we are committed to promoting and supporting the physical and mental health of all our staff and removing barriers to improve inclusion.

We encourage applicants to disclose experience of mental health problems so we can support them fully during our recruitment process and make any necessary reasonable adjustments. Any information disclosed will be kept confidential and separate from the job application form.

We are making significant strides to understand and continuously improve our employees experience and we are committed to implementing progressive diversity talent management.

See more here:
Lecturer/Senior Lecturer in Genetics job with UNIVERSITY OF GREENWICH | 260037 - Times Higher Education (THE)

COVID-19 Roundup: The Unvaccinated Fuel Hospitalizations; Genetic Link to Severe Illness; and Children’s Infection Rate – Baptist Health South Florida

This Virus Will Evolve: Concerns Grow Over Variants, New Surge Among the Unvaccinated

Just as public health officials feared, the combination of too many unvaccinated people and the more contagious delta strain of the coronavirus has led to new COVID-19 surges across the nation.

The vast majority of patients being hospitalized now for COVID-19 are unvaccinated, explains Sergio Segarra, M.D., the chief medical officer with Baptist Hospital, part of Baptist Health South Florida. And many of them are young adults in their 20s and 30s who are getting extremely sick.

Sergio Segarra, M.D., chief medical officer with Baptist Hospital, part of Baptist Health South Florida.

From the very beginning, that was a concern of mine that we do not get a substantial portion of the population vaccinated, said Dr. Segarra, who was interviewed by CNN this week on the latest surge in COVID-19 hospitalizations in Florida and nationwide.

The latest update from the Florida Health Department shows that 58 percent of the states population over the age of 12 has been vaccinated. Among the most populated South Florida counties, Miami-Dade registered a 73 percent vaccination rate; Broward 66 percent, and Palm Beach 62 percent, according to the latest data.

But there is a persistent group of people who, for whatever reason, are not getting vaccinated. The more people that get infected, the greater the likelihood that the virus evolves into more variants, said Dr. Segarra.

On Thursday, U.S. Surgeon General Vivek Murthy, M.D, released the first surgeon generals advisory of his time with the Biden administration, describing the urgent threat posed by the rise of false information about COVID-19 and vaccines. Misinformation has caused confusion and led people to decline COVID-19 vaccines, reject public health measures such as masking and physical distancing, and use unproven treatments, states the advisory.

The U.S. Centers for Disease Control and Prevention said this week that the delta variant is responsible for 58 percent of newly confirmed cases nationwide from June 20 through July 3. The COVID-19 vaccines approved for use in the U.S. effectively protects people from severe illness if they are infected with the delta strain of the virus, the CDC says.

With more people getting the virus, whether they get minor symptoms or get significantly ill and end up in the hospital, theres a greater chance that a variant is going to occur, explains Dr. Segarra. The virus will evolve.

The worse-case scenario, which fortunately has not occurred, says Dr. Segarra, is the emergence of a variant that is resistant to the currently available vaccines.

That hasnt happened yet, but thats something that does keep me up, says Dr. Segarra. Thats something that makes me worry. And I would hate to think that 10 years from now theyre going to say, Wow, those people back in 2021 could have gotten the vaccine, but they didnt. And now theres some terrible variant out there that is creating all kinds of havoc. So, that does worry me.

For more than a year since the beginning of the pandemic, researchers and clinicians have been trying to understand why some people develop severe COVID-19 illness, while others show few if any symptoms. Risk factors have included age and underlying medical conditions.

However, variations in the human genome have not been thoroughly investigated as a possible risk factor that determines a mild or severe response to a COVID-19 infection. That is, until now.

A new study published in Nature, led by the COVID-19 Host Genomics Initiative (HGI), confirms or newly identifies 13 genes that appear to play a role in susceptibility to the coronavirus, or that have an affect on the severity of illness. The researchers established international collaboration when the pandemic started to focus on genetics. This collaboration included about 3,000 researchers and clinicians and data from 46 studies involving more than 49,000 individuals with COVID-19.

HGI teams involved in the analysis include both academic laboratories and private firms from two dozen countries, including the U.S. Several of the 13 significant genes identified by researchers had previously been linked to other illnesses, including autoimmune diseases.

One example is the gene TYK2. Variants of this gene can increase susceptibility to infections by other viruses, bacteria and fungi, the studys authors write. Individuals who carry certain mutations in TYK2 are at increased risk of being hospitalized or developing critical illness from COVID-19. Another example is the gene DPP9. The authors found a variant in this gene that increases the risk of becoming critically ill with COVID-19. It is the same variant that can increase the risk of a rare pulmonary disease characterized by scarring of the lung tissue.

This study is important not only for advancing our understanding of human susceptibility to COVID-19; it also underlines the value of global collaborations for clarifying the human genetic basis of variability in susceptibility to infectious diseases, states a supplemental article to the study published in Nature.

Children represent a growing share of COVID-19 infections in the United States, while severe illness from the coronavirus remains rare among young kids and adolescents. Researchers caution, however, that studies are needed to determine long-term health effects of COVID-19 on children.

According to the American Academy of Pediatrics (AAP), children accounted for about 2 percent of infections at the onset of the pandemic last year. By the end of May of this year, kids accounted for 24 percent of new weekly infections, the AAP said. The cummulative percentage of COVID-19 cases involving children is about 14 percent, the organization states.

More than 4 million children have tested positive for COVID-19 in the U.S., 18,500 were hospitalized and 336 have died from the disease, according to the latest update from the AAP.

At this time, it still appears that severe illness due to COVID-19 is rare among children, the AAP states. However, there is an urgent need to collect more data on longer-term impacts of the pandemic on children, including ways the virus may harm the long-term physical health of infected children, as well as its emotional and mental health effects.

The U.S. Centers for Disease Control and Prevention (CDC) recommends everyone 12 years and older should get a COVID-19 vaccination to help protect against COVID-19. At this time, children 12 years and older are able to get the Pfizer-BioNTech COVID-19 vaccine. In May, the CDC and U.S. Food and Drug Administration approved the use of the Pfizer vaccine for adolescents after a clinical trial involving 2,260 12-to-15-year-olds found that the Pfizer-BioNTEch vaccines efficacy was 100 percent. This official CDC action opens vaccination to approximately 17 million adolescents in the United States and strengthens our nations efforts to protect even more people from the effects of COVID-19, stated CDC Director Rochelle Walensky in a statement.

Tags: COVID-19, COVID-19 vaccines

See the rest here:
COVID-19 Roundup: The Unvaccinated Fuel Hospitalizations; Genetic Link to Severe Illness; and Children's Infection Rate - Baptist Health South Florida

Marion scientists awarded grant to identify molecular mechanisms that drive cancer – Marion Star

MARION -A group of Ohio State University Marion faculty researchers were recently awarded a $156,000 federal grant from the National Institutes of Healths National Cancer Institute for research in the role of chromatin remodeling factors in DNA double strand break repair.

Assistant Professor of Molecular GeneticsDr. Ruben Petreaca, Associate Professor of Chemistry and BiochemistryDr Ryan Yoder, and Assistant Professor of Chemistry and BiochemistryDr. Renee Bouley are collaborating toward the goal of identifying molecular mechanisms that drive cancer, which if successful would make significant impact in the field of cancer research. The funds from the grant cover primarily undergraduate research salaries and materials between May 1, 2021, and April 30, 2023.

When considering the groups research, Petreaca shared that one challenge to understanding the genetic change in cancer cells is the complexity of the different processes that participate in DNA damage repair.

Errors in some of these repair processes cause accumulation of various forms of DNA damage that eventually leads to cellular transformation and cancer, said Petreaca.

Here we propose novel protein modeling and genetic analysis to understand the interactions between various repair complexes and determine the roles they play in promoting accurate repair, he added.

As a scientist and researcher, Petreaca boiled it down to two basic conceptsthe importance of grants to the discovery process and involving students in research.

It means we can keep doing science, said Petreaca. More importantly, this grant will be used exclusively to fund undergraduate research at Marion.

Yoder echoed Petreacas sentiment about the funding directly benefitting undergraduate research and added his thoughts on the unique aspect of collaboration between different departments and majors working toward a unified goal.

I think its important to stress the interdisciplinary nature of this work, said Yoder.We have faculty with three very different backgrounds (molecular genetics, biochemistry, molecular modeling) who are all bringing our own strengths to this effort.

That means our students who work on this project will be exposed to many different research methods and techniques, he added, which can only benefit them as they move forward in their educational journey.

Having the resources and backing of a tier 1 research university, while having the advantages of a small campus setting to enhance such a collaborative project is at the core of what Ohio State Marion is all about, Yoder shared.

The intimate setting of Ohio State Marion, along with (the resources available at) our Science & Engineering Building, Yoder said, allows for such interdisciplinary research to thrive and provide our students such opportunities to participate in cancer research.

According to Bouley, even before she officially began her tenure on campus, she began working on a project with Dr. Petreaca and got advice on purchasing start-up equipment.

I love how collaborative the science faculty are at Ohio State Marion, said Bouley.

It has been so helpful to team up with other faculty in different fields of expertise to tackle challenging problems such as understanding what causes cancer to develop, she said.

Much like Petreaca and Yoder, for Bouley the grant is about supplying their research materials and hiring bright and energetic young minds who will greatly benefit their future education and career by being involved in research on the undergraduate level.

This grant is currently supporting several undergraduate students and most importantly for my lab, Bouley said, research supplies to be able to conduct biochemistry experiments.

The recent Pelotonia fellow Lauren Frank is currently working on purifying proteins and modeling protein-protein interactions as part of this grant, she explained.

Lauren Frank is the campuss third Pelotonia Undergraduate Fellowship recipient in the past four years, demonstrating the campuss strong science programs and the level of faculty engagement with students in interdisciplinary research.

View original post here:
Marion scientists awarded grant to identify molecular mechanisms that drive cancer - Marion Star

Fact Check-Fruit juices and coffee cannot produce a positive test result for COVID-19 – Reuters

Updated to correct paragraph formatting

Social media users claiming that fruit juices and coffee have tested positive for COVID-19 have misunderstood how lateral flow devices (LFDs) work. Videos allegedly showing a positive test result actually reveal what happens when devices are degraded by using substances other than those intended.

Examples of the claim can be found here, here here.

Imagine just how many hundreds of thousands of fake positives have been reported as actual covid, one individual said in a Facebook post (here).

Many of the users have tested LFDs with substances other than saliva to prove they are ineffective. They include examples of the devices showing two pink lines, indicative of a positive COVID-19 result.

However, this is misleading.

The beverages and other solutions used do not contain the COVID virus, Professor Mark Lorch, professor of public engagement and science communication and interim head of department for chemistry, biochemistry and chemical engineering at the University of Hull, told Reuters by email.

He said that while results might appear to be positive, they reveal something else. Instead, the acidity of the juices, soft drinks, coffee etc. disrupt the delicate antibodies on the test devices and so corrupt the test results.

Inside a lateral flow test, there is a strip known as the conjugation pad where antibodies are attached to gold nanoparticles. Those antibodies bind with virus particles should the test encounter the coronavirus (Lateral Flow Test Teardown). After taking a swab from the throat and nose, the sample is mixed with a buffer to ensure optimum pH before dripping it onto the strip (here , here , here and here).

These tests rely on molecular components such as the antibodies and functionalised nanoparticles being able to bind and this is determined by electrostatic interactions between the components, Andrea Sella, a professor of chemistry at University College London (UCL), told Reuters.

When it comes to biological components, most of them have components that are very pH sensitive. For example, if you change the pH, you can completely change the charge of a protein from, say, positive to negative and the result is that it will not stick correctly.

Sella added that it was therefore unsurprising that LFDs were disrupted when testing substances such as Coca-Cola and orange juice, considering the pH is significantly more acidic than biological fluids.

The two resulting red lines on an LFD do not have any meaning in these circumstances, he said, because youve wrecked the underlying chemistry that allows you to do the delicate detection you want.

Moreover, the US Food and Drug Administration (FDA) has warned that there is potential for false positive results with antigen tests, including when users do not follow the instructions (here).

A clinical evaluation into lateral flow antigen tests by the University of Oxford and Public Health England (PHE) found that the tests detect the most infectious COVID cases (here, here, here).

Reuters previously fact-checked the claim that Coca-Cola produces a positive COVID-19 test (here).

False. Fruit juices and coffee do not test positive for COVID-19. The acidity in such substances corrupts lateral flow devices.

This article was produced by the Reuters Fact Check team. Read more about our fact-checking work here .

Excerpt from:
Fact Check-Fruit juices and coffee cannot produce a positive test result for COVID-19 - Reuters

Virginia Tech researchers receive $2.7 million grant to study mosquito’s biological timing – News-Medical.Net

Mosquitoes may be small, but they are a formidable foe. Not only can they smell over 400 chemicals that we emit and detect the carbon dioxide we breathe out, but they can even adapt their daily behavior in response to our own.

With the help of a $2.7 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), researchers at Virginia Tech are now investigating how mosquitoes adjust their olfactory, or smelling, rhythms in response to changes in our own daily activity.

Mosquitoes are sometimes described as the deadliest animal on Earth. What we are seeing is an increase in the rate of mosquitoes that become resistant to insecticides and have some other level of behavioral resistance. We need another tool or other tools to control mosquito populations."

Clment Vinauger, Principal Investigator on the Project and Assistant Professor, Department of Biochemistry, College of Agriculture and Life Sciences

Vinauger alongside assistant professor Chlo Lahondre and university distinguished professor Jake Tu, both from the Department of Biochemistry in the College of Agriculture and Life Sciences and affiliated faculty members of the Center for Emerging, Zoonotic, and Arthropod-borne Pathogens, an arm of the Fralin Life Sciences Institute, received the grant to support a five-year project to study mosquito's biological timing, or chronobiology.

The research will look at the molecular and cellular levels of the mosquito brain to find what allows mosquitoes to adapt and finetune their biological rhythms.

"Mosquitoes have rhythms, exactly like us," said Lahondre, who is also an affiliated faculty member of Fralin's Global Change Center. "We are very active during the day and then we go to sleep. For mosquitoes, we don't know a lot about their biological rhythm, so we are trying to understand how they process information at different times of the day and what is going on in their brain."

The specific mosquito species being studied is Aedes aegypti, a primary vector for Zika, dengue, and yellow fever. These invasive mosquitoes prefer to feed on people and live throughout the Southern United States, including Virgina.

With a more urbanized environment and a changing climate, the ranges of these mosquitoes and other mosquito species could expand over the coming years. Adding to that, large populations of mosquitoes are becoming both physiologically resistant to insecticides and behaviorally resistant to other control methods like bed nets.

"With climate change, there is a potential impact on mosquitoes' geographic distribution," Lahondre said. "As temperatures are rising, mosquitoes can move north, and that exposes people to the potential diseases that they can transmit."

Understanding Mosquito Behavior to Prevent Disease SpreadPlay

Video Credit: Virginia Tech

Mosquitoes are resilient beings. No matter how many showers we may take, mosquitoes can still smell and find us. As found by Vinauger and Lahondre's past research, mosquitoes can remember host smells and effectively track their victims.

To be the most efficient bloodsuckers on earth, mosquitoes also need to be active most when they can find a meal the easiest. That time is usually when we are most vulnerable and easy to access, which often aligns with our daily activities and circadian rhythms.

Mosquitoes also experience biological rhythms with their sense of smell. At one stage of the day, they reach a low point in odor sensitivity that eventually rises to a smelling peak. Their ability to detect and process host odors then declines, just as our senses decline late at night.

The more in tune their rhythm is with our availability as hosts, the more mosquitoes can feed and the more disease is spread.

Understanding what molecular and cellular processes underpin these rhythms could prove crucial in the fight against mosquitoes that cause disease outbreaks.

"What we are proposing here is to try to understand how mosquitoes keep out-smarting our control strategies," said Vinauger, who is also an affiliated faculty member of the Fralin Life Sciences Institute and Center for Emerging, Zoonotic, and Arthropod-borne Pathogens. "How do they synchronize to a new human environment or the fact that their host is available only at certain times compared to others?"

Using miniature mosquito-helmets that track brain activity in a virtual reality setting, the team of researchers will be able to determine how mosquitoes modulate their olfactory rhythms and their behavioral rhythms in response to host cues.

The research will also investigate how circadian clocks control mosquitoes' brain and antenna activity by "knocking out" the gene that controls a mosquito's sense of time, effectively creating an arrhythmic, mutant mosquito.

Put together with single-cell sequencing of the mosquito brain, the researchers will be able to identify where and what molecules or cells control how mosquitoes synchronize their rhythms with ours.

"If we can better understand how they work, we can have a better set of tools to use for their control," Lahondre said. "Understanding why they bite and how they process information at a specific time of the day can lead to finding key information for mosquito control."

As mosquitoes become more resistant to insecticides and spread at a rapid rate, finding new targets to disrupt their feeding habits is all the more important.

Through this NIH's NIAID grant, Vinauger and his team are hoping to find any rhythmic targets that mosquito control professionals can exploit. All it takes is finding out just what makes a mosquito tick.

Go here to read the rest:
Virginia Tech researchers receive $2.7 million grant to study mosquito's biological timing - News-Medical.Net

One Major Side Effect of Eating Plant-Based Meat, Says New Study | Eat This Not That – Eat This, Not That

Every year brings a fresh wave of food trends, and 2021 seems to be shaping up as the year plant-based meats finally caught hold. Despite veggie burgers being on the market for decades, the wave of fast-food choices is highlighting these alternativesfrom Burger King's Impossible Whopper to Panda Express trying out a plant-based orange chicken with Beyond Meat products.

But a new study in Scientific Reports suggests that when it comes to nutrition, they're not exactly an even swap.

Researchers at Duke University noted that when you look at nutrition labels, the amount of vitamins, fats, and protein are very similar to real beef. However, using an approach known as "metabolomics," they were able to examine the biochemistry for 18 plant-based meat products and assess their metabolites.

RELATED:Delicious Foods You Can Eat on a Plant-Based Diet

Metabolites are essential for signaling between cells and converting food into energy, and about half of them come from our diet. When the researchers compared samples of plant-based meat with grass-fed ground beef, they found significant differences between the two in terms of metabolite contentup to 90% in some cases.

The beef contained 22 metabolites that were lacking in the plant substitute, including several amino acids and vitamins. Several of these are known to have important anti-inflammatory roles in the body, the researchers noted, such as omega-3 fatty acids, glucosamine, and creatine, which were all found in larger quantities in the real beef samples.

They aren't suggesting avoiding plant-based meat altogetherin fact, the plant-based products contained 31 metabolites that were missing in the meat. These included vitamin C and phytosterols, which are naturally occurring compounds found in plant cell membranes. These compounds are particularly important for lowering cholesterol, which is why plant-based eating is regularly touted for heart health.

In general, that means adding in these alternative meat options could be helpful for getting a full range of beneficial metabolites.

Unless you prefer to eat only plant-based foods, including both plant and animal meats in your diet could yield more nutritional advantages, says lead researcher Stephan van Vliet, Ph.D., a researcher at Duke Molecular Physiology Institute.

"The takeaway is that there are large differences between meat and a plant-based meat alternative," he states. "However, plant and animal foods can be complementary, because they provide different nutrients."

For more, be sure to check out:

See the original post here:
One Major Side Effect of Eating Plant-Based Meat, Says New Study | Eat This Not That - Eat This, Not That

New Approach Could Boost the Search for Life in Otherworldly Oceans – Scientific American

The hottest spots in the search for alien life are a few frigid moons in the outer solar system, each known to harbor a liquid-water ocean beneath its icy exterior. There is Saturns moon Titan, which hides a thick layer of briny water beneath a frozen surface dotted with lakes of liquid hydrocarbon. Titans sister Saturnian moon Enceladus has revealed its subsurface sea with geyserlike plumes venting from cracks near its south pole. Plumes also emanate from a moon that is one planet closer to the sun: Jupiters Europa, which boasts a watery deep so vast that, by volume, it dwarfs all of Earths oceans combined. Each of these aquatic extraterrestrial locales might be the site of a second genesis, an emergence of life of the same sort that occurred on Earth billions of years ago.

Astrobiologists are now pursuing multiple interplanetary missions to learn whether any of these ocean-bearing moons actually possess more than mere waternamely, habitability, or the nuanced geochemical conditions required for life to arise and flourish. NASAs instrument-packed Europa Clipper spacecraft, for example, could begin its orbital investigations of Jupiters enigmatic moon by 2030. And another mission, a nuclear-fueled flying drone called Dragonfly, is scheduled to touch down on Titan as early as 2036. As impressive as these missions are, however, they are only preludes to future efforts that could more directly hunt for alien life itself. But in those strange sunless places so unlike our own world, how will astrobiologists know life when they see it?

More often than not, the biosignatures scientists look for in such searches are subtle chemical tracers of lifes past or current presence on a planet rather than anything so obvious as a fossilized form protruding from a rock or a little green humanoid waving hello. The instruments on NASAs Perseverance Mars rover, for instance, can detect organic compounds and salts in and around its landing site: Jezero Crater, a dry lakebed that may contain evidence of past life. And in the fall of 2020 some astronomers telescopically studying Venus may have teased out the presence of phosphine gas there, a possible by-product of putative microbes floating in temperate regions of the planets atmosphere.

The trouble is that many simple biosignatures can be produced both by living things and through abiotic geochemical processes. Much of the phosphine on Earth comes from microbes, but Venuss phosphine, if it exists at all, could potentially be linked to erupting volcanoes rather than some alien ecosystem in its clouds. Such ambiguities can lead to false positives, cases in which scientists think they see life where none exists. At the same time, if organisms possess radically different biochemistry and physiology from that of terrestrial creatures, scientists could instead encounter false negatives, cases in which they do not recognize life despite having evidence for its presence. Especially when contemplating prospects for life on distinctly alien worlds such as the ocean moons of the outer solar system, researchers must carefully navigate between these two interlinked hazardsthe Scylla and Charybdis of astrobiology.

Now, however, a study recently published in the Bulletin of Mathematical Biology offers a novel approach. By shifting attention from specific chemical tracerssuch as phosphineto the broader question of how biological processes reorganize materials across entire ecosystems, the papers authors say, astrobiologists could illuminate new types of less ambiguous biosignatures. These clues would be suitable for discovering life in its myriad possible formseven if that life employed profoundly unearthly biochemistry.

The study relies on stoichiometry, which measures the elemental ratios that appear in the chemistry of cells and ecosystems. The researchers began with the observation that within groups of cells, chemical ratios vary with striking regularity. The classic example of this regularity is the Redfield ratioa 16:1 average proportion of nitrogen to phosphorus displayed with remarkable consistency by phytoplankton blooms throughout Earths oceans. Other kinds of cells, such as certain types of bacteria, also exhibit their own characteristically consistent ratios. If the regularity of chemical ratios within cells is a universal property of biological systems, here or anywhere else in the cosmos, then careful stoichiometry could be the key to eventually discovering life on an alien world.

Importantly, however, these elemental proportions change in accordance with cell size, allowing for an additional check on any curiously consistent but possibly abiotic chemical ratios on another world. In bacteria, for instance, as cells get larger, concentrations of protein molecules decrease, whereas concentrations of nucleic acids increase. In contrast to groups of nonliving particles, biological particles will display ratios that systematically change with cell size, explains Santa Fe Institute researcher Chris Kempes, who led the new study, which expanded on prior work by co-author Simon Levin, also at the Santa Fe Institute. The trick is to devise a general theory of how, exactly, the various sizes of cells affect elemental abundanceswhich is precisely what Kempes, Levin and their colleagues did.

They focused on the fact that, at least for Earth life, as cell sizes increase in a fluid, their abundance decreases in a mathematically patterned wayspecifically, as a power law, the rate of which can be expressed by a negative exponent. This suggests that, if astrobiologists know the size distribution of cells (or cell-like particles) in a fluid, they can predict the elemental abundances within those materials. In essence, this could be a potent recipe for determining whether a group of unknown particles, say within a sample of Europan seawater, harbors anything alive. If we observe a system where we have particles with systematic relationships between elemental ratios and size, and the surrounding fluid does not contain these ratios, Kempes explains, we have a strong signal that the ecosystem may contain life.

The studys emphasis on such ecological biosignatures is the latest in a slow-simmering, decades-long quest to link life not only to the fundamental limitations of physics and chemistry but also to the specific environments in which it appears. It would, after all, be somewhat naive to assume organisms on the sunbathed surface of a warm, rocky planet would have the very same chemical biosignatures as those dwelling within the lightless depths of an oceanic moon. There has been a constant evolution in ideas, in approaches, and thats really important, explains Jim Green, NASAs chief scientist, who was not involved in the new study. Now we are entering an era where we can go after what we know about how life has evolved and apply that as a general principle.

So what does it take to bring this more holistic approach to biosignatures to our studies of worlds such as Europa, Titan and Enceladus? At the moment, Green explains, it will take more than the space agencys Europa Clipper orbiterperhaps a follow-up mission to the surface would suffice. Through Clipper, we want to take much more detailed measurements, fly through the plume, study the evolution of Europa over a period of time and capture high-resolution images, he says. This would take us to the next step, which would be to get down to the ground. Thats where the next generation of ideas and instruments need to come in.

Looking for the ecological biosignatures described by Kempes and his colleagues would require instrumentation that measures the size distribution and chemical composition of cells within their native fluid. On Earth, the technique that scientists use to sort cells by size is called flow cytometry, and it is used frequently in marine environments. But performing cytometry in an alien moons subsurface ocean would be far more challenging than merely sending instrumentation there: Because of the paucity of available energy in those sunlight-starved abysses, scientists expect any life there to be single-celled, extremely small and relatively sparse. To capture such organisms in the first place would require careful filtering and then a refined flow cytometer that would measure particles of this size range.

Our current flow cytometers are not up to that task, explains Sarah Maurer, a biochemist and astrobiologist at Central Connecticut University, who was not involved with the study. Many kinds of cells simply do not get picked up, and there are cell types that require extensive preparation or they wont go through a cytometer, she says. To work in space, instruments to filter and sort cells would need both refinement on Earth and miniaturization for spaceflight.

Progress is already being made on both fronts, according to study co-author Heather Graham of the NASA-funded Laboratory for Agnostic Biosignatures and the agencys Goddard Space Flight Center. The next steps, she says, will be to deploy new tools at marginally habitable field sites around the globe that play host to some of Earths most extreme and impoverished ecosystems. Once astrobiologists begin routinely discerning the distinctive chemical ratios associated with living ecosystems in our own planets quiescent waters, they can fine-tune the specifications for spaceflight-capable devicesand, just maybe, at last reveal a second genesis, written within the mathematics of a subsurface oceans chemistry.

See the original post here:
New Approach Could Boost the Search for Life in Otherworldly Oceans - Scientific American

Edward Westhead Obituary (1930 – 2021) – Amherst, MA – Daily Hampshire Gazette – Legacy.com

Edward Westhead

Amherst, MA Edward W. Westhead passed away from cancer at Cooley-Dickenson Hospital on Tuesday, June 1 at age 90, three weeks shy of his 91 st birthday.

A distinguished biochemist, with a passion for learning and broad interests, Ed enjoyed life to its fullest both in the lab and outside his chosen field. He was born in Philadelphia, PA on June 19, 1930 to Edward and Eleanore Westhead, the oldest of five children. He graduated high school from Archmere Academy in Delaware, received his Bachelor of Science (1951) and Masters of Science (1953) from Haverford College, and his PhD in Chemistry from the Polytechnic Institute of Brooklyn (1956).

Ed established his own lab at Dartmouth Medical School in the Department of Biochemistry after post-doctoral work at the University of Uppsala and at the University of Minnesota. He was subsequently recruited by the University of Massachusetts, Amherst to form a new Department of Biochemistry (1966) and, later, became the first director of the UMass PhD program in molecular and cellular biology. He held visiting professorship positions at the California Institute of Technology (1971); Oxford University (1972-73); University of Innsbruck (1979-80); and the University of Milan (1987; 1993). His research concentrated on topics in enzyme biochemistry and neurobiology; his work was well-published and he served in numerous professional organizations. He followed developments in his field and kept in touch with former students his entire life.

Beyond his work, Ed read broadly, enjoyed concerts and museum shows, and delighted in the interests and achievements of his family and many friends. He loved to travel, seizing any opportunity whether work-related or a personal invitation to visit, and consequently knew people almost everywhere he went. Italy held a special place in his heart; the year he spent with his wife Evelyn in Lucca was one of his fondest times, allowing him to explore his love of history and culture and savor a favorite cuisine. He had an astonishing memory for exceptional food and wine and would travel miles out of his way for a delicious loaf of bread or a dish of homemade ice cream. In his later years he began chronicling his adventures, including a solo trip he made down the Mekong river in Thailand in a foldable kayak in the mid-1950's.

Ed was an avid outdoorsman and enjoyed hiking, biking, tennis and skiing up until the last months of his life. A lifelong member of the Appalachian Mountain Club, he volunteered into his eighties on their trail crews, clearing brush and repairing bridges for the upcoming season. He started skiing in the western US at Alta in the 1950's and one of his life's greatest pleasures was qualifying for a free season ski pass there when he turned 80.

Ed is survived by his beloved wife of 24 years, Evelyn A. Villa, MD, his daughter Victoria Westhead (John), his son Edward G. Westhead, grandchildren Abby and Nat Levy-Westhead, two sisters, Barbara Lawler (Dan) and Eileen Hall (Bob), and numerous nieces and nephews. He is also survived by six stepchildren: Liz Diton (Jeff), Janet Vanoni (Pete), Karen Shailor (Chris), Mariella Villa (Ryan), Arthur Villa (Jess), and Jason Villa, their children and grandchildren.

A celebration of Ed's life will be planned for 2022. Please contact [emailprotected] or [emailprotected] if you wish to be notified of the date.

Published by Daily Hampshire Gazette on Jul. 14, 2021.

Read more:
Edward Westhead Obituary (1930 - 2021) - Amherst, MA - Daily Hampshire Gazette - Legacy.com